1-9 of 9
James P. Stevenson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy

Daniel H. Sterman, Evan Alley, James P. Stevenson, Joseph Friedberg, Susan Metzger, Adri Recio, Edmund K. Moon, Andrew R. Haas, Anil Vachani, Sharyn I. Katz, Jing Sun, Daniel F. Heitjan, Wei-Ting Hwang, Leslie Litzky, Jennifer H. Yearley, Kay See Tan, Emmanouil Papasavvas, Paul Kennedy, Luis J. Montaner, Keith A. Cengel, Charles B. Simone, II, Melissa Culligan, Corey J. Langer, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (15): 3791–3800.
https://doi.org/10.1158/1078-0432.CCR-15-2133
Published: 31 July 2016
View article titled, Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
Open the PDF for Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy in another window
Includes: Supplementary data
Journal Articles

New Strategies in Non–Small Cell Lung Cancer: Improving Outcomes in Chemoradiotherapy for Locally Advanced Disease

Ramesh Rengan, Amit M. Maity, James P. Stevenson, Stephen M. Hahn
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4192–4199.
https://doi.org/10.1158/1078-0432.CCR-10-2760
Published: 05 July 2011
View article titled, New Strategies in Non–Small Cell Lung Cancer: Improving Outcomes in Chemoradiotherapy for Locally Advanced Disease
Open the PDF for New Strategies in Non–Small Cell Lung Cancer: Improving Outcomes in Chemoradiotherapy for Locally Advanced Disease in another window
Journal Articles

Phase I Trial of Combretastatin A-4 Phosphate with Carboplatin

Joshua H. Bilenker, Keith T. Flaherty, Mark Rosen, Lisa Davis, Maryann Gallagher, James P. Stevenson, Weijing Sun, David Vaughn, Bruce Giantonio, Ross Zimmer, Mitchell Schnall, Peter J. O'Dwyer
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1527–1533.
https://doi.org/10.1158/1078-0432.CCR-04-1434
Published: 02 March 2005
View article titled, Phase I Trial of Combretastatin A-4 Phosphate with Carboplatin
Open the PDF for Phase I Trial of Combretastatin A-4 Phosphate with Carboplatin in another window
Journal Articles

A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer

Neil E. Martin, Thomas B. Brunner, Krystina D. Kiel, Thomas F. DeLaney, William F. Regine, Mohammed Mohiuddin, Ernest F. Rosato, Daniel G. Haller, James P. Stevenson, Debbie Smith, Barnali Pramanik, Joel Tepper, Wesley K. Tanaka, Briggs Morrison, Paul Deutsch, Anjali K. Gupta, Ruth J. Muschel, W. Gillies McKenna, Eric J. Bernhard, Stephen M. Hahn
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (16): 5447–5454.
https://doi.org/10.1158/1078-0432.CCR-04-0248
Published: 24 August 2004
View article titled, A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer
Open the PDF for A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer in another window
Journal Articles

Phase I and Pharmacokinetic Trial of the Novel Taxane BMS-184476 Administered as a 1-Hour Intravenous Infusion in Combination with Cisplatin Every 21 Days

Weijing Sun, James P. Stevenson, Maryann L. Gallagher, David Vaughn, Steven M. Hahn, Daniel G. Haller, Marvin Cohen, Justin Kopit, Gilles Gallant, Peter J. O’Dwyer
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5221–5227.
Published: 12 November 2003
View article titled, Phase I and Pharmacokinetic Trial of the Novel Taxane BMS-184476 Administered as a 1-Hour Intravenous Infusion in Combination with Cisplatin Every 21 Days
Open the PDF for Phase I and Pharmacokinetic Trial of the Novel Taxane BMS-184476 Administered as a 1-Hour Intravenous Infusion in Combination with Cisplatin Every 21 Days in another window
Journal Articles

Phase I and Pharmacokinetic Trial of the Proapoptotic Sulindac Analog CP-461 in Patients with Advanced Cancer

Weijing Sun, James P. Stevenson, James M. Gallo, Maryann Redlinger, Daniel Haller, Kenneth Algazy, Bruce Giantonio, Hector Alila, Peter J. O’Dwyer
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (10): 3100–3104.
Published: 01 October 2002
View article titled, Phase I and Pharmacokinetic Trial of the Proapoptotic Sulindac Analog CP-461 in Patients with Advanced Cancer
Open the PDF for Phase I and Pharmacokinetic Trial of the Proapoptotic Sulindac Analog CP-461 in Patients with Advanced Cancer in another window
Journal Articles

Phase I Trial of the Cryptophycin Analogue LY355703 Administered as an Intravenous Infusion on a Day 1 and 8 Schedule Every 21 Days

James P. Stevenson, Weijing Sun, Maryann Gallagher, Robert Johnson, David Vaughn, Lynn Schuchter, Kenneth Algazy, Stephen Hahn, Nathan Enas, Diane Ellis, Donald Thornton, Peter J. O’Dwyer
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (8): 2524–2529.
Published: 01 August 2002
View article titled, Phase I Trial of the Cryptophycin Analogue LY355703 Administered as an Intravenous Infusion on a Day 1 and 8 Schedule Every 21 Days
Open the PDF for Phase I Trial of the Cryptophycin Analogue LY355703 Administered as an Intravenous Infusion on a Day 1 and 8 Schedule Every 21 Days in another window
Journal Articles

A Phase I Trial of the Farnesyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Lung and Head and Neck Cancer

Stephen M. Hahn, Eric J. Bernhard, William Regine, Mohammed Mohiuddin, Daniel G. Haller, James P. Stevenson, Debbie Smith, Barnali Pramanik, Joel Tepper, Thomas F. DeLaney, Krystina D. Kiel, Briggs Morrison, Paul Deutsch, Ruth J. Muschel, W. Gillies McKenna
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 1065–1072.
Published: 01 May 2002
View article titled, A Phase I Trial of the Farnesyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Lung and Head and Neck Cancer
Open the PDF for A Phase I Trial of the Farnesyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Lung and Head and Neck Cancer in another window
Journal Articles

c-raf-1 Depletion and Tumor Responses in Patients Treated with the c-raf-1 Antisense Oligodeoxynucleotide ISIS 5132 (CGP 69846A)

Peter J. O’Dwyer, James P. Stevenson, Maryann Gallagher, Amy Cassella, Irina Vasilevskaya, Brett P. Monia, Jon Holmlund, F. Andrew Dorr, Kang-Shen Yao
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 3977–3982.
Published: 01 December 1999
View article titled, c-<em>raf</em>-1 Depletion and Tumor Responses in Patients Treated with the c-<em>raf</em>-1 Antisense Oligodeoxynucleotide ISIS 5132 (CGP 69846A)
Open the PDF for c-<em>raf</em>-1 Depletion and Tumor Responses in Patients Treated with the c-<em>raf</em>-1 Antisense Oligodeoxynucleotide ISIS 5132 (CGP 69846A) in another window